40 research outputs found
Recommended from our members
Direct trafficking pathways from the Golgi apparatus to the plasma membrane.
In eukaryotic cells, protein sorting is a highly regulated mechanism important for many physiological events. After synthesis in the endoplasmic reticulum and trafficking to the Golgi apparatus, proteins sort to many different cellular destinations including the endolysosomal system and the extracellular space. Secreted proteins need to be delivered directly to the cell surface. Sorting of secreted proteins from the Golgi apparatus has been a topic of interest for over thirty years, yet there is still no clear understanding of the machinery that forms the post-Golgi carriers. Most evidence points to these post-Golgi carriers being tubular pleomorphic structures that bud from the trans-face of the Golgi. In this review, we present the background studies and highlight the key components of this pathway, we then discuss the machinery implicated in the formation of these carriers, their translocation across the cytosol, and their fusion at the plasma membrane
SNX19 restricts endolysosome motility through contacts with the endoplasmic reticulum.
The ability of endolysosomal organelles to move within the cytoplasm is essential for the performance of their functions. Long-range movement involves coupling of the endolysosomes to motor proteins that carry them along microtubule tracks. This movement is influenced by interactions with other organelles, but the mechanisms involved are incompletely understood. Herein we show that the sorting nexin SNX19 tethers endolysosomes to the endoplasmic reticulum (ER), decreasing their motility and contributing to their concentration in the perinuclear area of the cell. Tethering depends on two N-terminal transmembrane domains that anchor SNX19 to the ER, and a PX domain that binds to phosphatidylinositol 3-phosphate on the endolysosomal membrane. Two other domains named PXA and PXC negatively regulate the interaction of SNX19 with endolysosomes. These studies thus identify a mechanism for controlling the motility and positioning of endolysosomes that involves tethering to the ER by a sorting nexin
Molecular mechanism for the subversion of the retromer coat by the Legionella effector RidL
Microbial pathogens employ sophisticated virulence strategies to
cause infections in humans. The intracellular pathogen Legionella
pneumophila encodes RidL to hijack the host scaffold protein
VPS29, a component of retromer and retriever complexes critical for
endosomal cargo recycling. Here, we determined the crystal structure
of L. pneumophila RidL in complex with the human VPS29?VPS35
retromer subcomplex. A hairpin loop protruding from RidL inserts
into a conserved pocket on VPS29 that is also used by cellular ligands,
such as Tre-2/Bub2/Cdc16 domain family member 5 (TBC1D5) and
VPS9-ankyrin repeat protein for VPS29 binding. Consistent with the
idea of molecular mimicry in protein interactions, RidL outcompeted
TBC1D5 for binding to VPS29. Furthermore, the interaction of RidL
with retromer did not interfere with retromer dimerization but was
essential for association of RidL with retromer-coated vacuolar and
tubular endosomes. Our work thus provides structural and mechanistic
evidence into how RidL is targeted to endosomal membranes.ACKNOWLEDGMENTS: We thank Ander Vidaurrazaga (Centro de Investigación Cooperativa en Biociencias) for technical assistance and Devanand Bondage (National Institute of Child Health and Human Development) for proliferation assays of Legionella pneumophila. This study made use of the Diamond Light Source (Oxfordshire, United Kingdom), the European Synchrotron Radiation Facility (Grenoble, France), and the ALBA synchrotron beamline BL13-XALOC, funded in part by the Horizon 2020 programme of the European Union, iNEXT (H2020 Grant 653706). We thank all the staff from these facilities for technical and human support. This work was supported by the Spanish Ministry of Economy and Competitiveness Grant BFU2014-59759-R (to A.H.); the Severo Ochoa Excellence Accreditation SEV-2016-0644; and the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human development (Projects ZIA HD001607 and ZIA HD008893). M.R.-M. is supported by a pre-doctoral fellowship from the Basque Government (PRE_2016_2_0249)
Recommended from our members
The autophagy protein ATG9A promotes HIV-1 infectivity.
BACKGROUND: Nef is a multifunctional accessory protein encoded by HIV-1, HIV-2 and SIV that plays critical roles in viral pathogenesis, contributing to viral replication, assembly, budding, infectivity and immune evasion, through engagement of various host cell pathways. RESULTS: To gain a better understanding of the role of host proteins in the functions of Nef, we carried out tandem affinity purification-mass spectrometry analysis, and identified over 70 HIV-1 Nef-interacting proteins, including the autophagy-related 9A (ATG9A) protein. ATG9A is a transmembrane component of the machinery for autophagy, a catabolic process in which cytoplasmic components are degraded in lysosomal compartments. Pulldown experiments demonstrated that ATG9A interacts with Nef from not only HIV-1 and but also SIV (cpz, smm and mac). However, expression of HIV-1 Nef had no effect on the levels and localization of ATG9A, and on autophagy, in the host cells. To investigate a possible role for ATG9A in virus replication, we knocked out ATG9A in HeLa cervical carcinoma and Jurkat T cells, and analyzed virus release and infectivity. We observed that ATG9A knockout (KO) had no effect on the release of wild-type (WT) or Nef-defective HIV-1 in these cells. However, the infectivity of WT virus produced from ATG9A-KO HeLa and Jurkat cells was reduced by ~ fourfold and eightfold, respectively, relative to virus produced from WT cells. This reduction in infectivity was independent of the interaction of Nef with ATG9A, and was not due to reduced incorporation of the viral envelope (Env) glycoprotein into the virus. The loss of HIV-1 infectivity was rescued by pseudotyping HIV-1 virions with the vesicular stomatitis virus G glycoprotein. CONCLUSIONS: These studies indicate that ATG9A promotes HIV-1 infectivity in an Env-dependent manner. The interaction of Nef with ATG9A, however, is not required for Nef to enhance HIV-1 infectivity. We speculate that ATG9A could promote infectivity by participating in either the removal of a factor that inhibits infectivity or the incorporation of a factor that enhances infectivity of the viral particles. These studies thus identify a novel host cell factor implicated in HIV-1 infectivity, which may be amenable to pharmacologic manipulation for treatment of HIV-1 infection
Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
[This corrects the article DOI: 10.1371/journal.pbio.3001480.]
Arrhythmia and death following percutaneous revascularization in ischemic left ventricular dysfunction: Prespecified analyses from the REVIVED-BCIS2 trial
BACKGROUND: Ventricular arrhythmia is an important cause of mortality in patients with ischemic left ventricular dysfunction. Revascularization with coronary artery bypass graft or percutaneous coronary intervention is often recommended for these patients before implantation of a cardiac defibrillator because it is assumed that this may reduce the incidence of fatal and potentially fatal ventricular arrhythmias, although this premise has not been evaluated in a randomized trial to date. METHODS: Patients with severe left ventricular dysfunction, extensive coronary disease, and viable myocardium were randomly assigned to receive either percutaneous coronary intervention (PCI) plus optimal medical and device therapy (OMT) or OMT alone. The composite primary outcome was all-cause death or aborted sudden death (defined as an appropriate implantable cardioverter defibrillator therapy or a resuscitated cardiac arrest) at a minimum of 24 months, analyzed as time to first event on an intention-to-treat basis. Secondary outcomes included cardiovascular death or aborted sudden death, appropriate implantable cardioverter defibrillator (ICD) therapy or sustained ventricular arrhythmia, and number of appropriate ICD therapies. RESULTS: Between August 28, 2013, and March 19, 2020, 700 patients were enrolled across 40 centers in the United Kingdom. A total of 347 patients were assigned to the PCI+OMT group and 353 to the OMT alone group. The mean age of participants was 69 years; 88% were male; 56% had hypertension; 41% had diabetes; and 53% had a clinical history of myocardial infarction. The median left ventricular ejection fraction was 28%; 53.1% had an implantable defibrillator inserted before randomization or during follow-up. All-cause death or aborted sudden death occurred in 144 patients (41.6%) in the PCI group and 142 patients (40.2%) in the OMT group (hazard ratio, 1.03 [95% CI, 0.82–1.30]; P =0.80). There was no between-group difference in the occurrence of any of the secondary outcomes. CONCLUSIONS: PCI was not associated with a reduction in all-cause mortality or aborted sudden death. In patients with ischemic cardiomyopathy, PCI is not beneficial solely for the purpose of reducing potentially fatal ventricular arrhythmias. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01920048
Recommended from our members
Direct trafficking pathways from the Golgi apparatus to the plasma membrane.
In eukaryotic cells, protein sorting is a highly regulated mechanism important for many physiological events. After synthesis in the endoplasmic reticulum and trafficking to the Golgi apparatus, proteins sort to many different cellular destinations including the endolysosomal system and the extracellular space. Secreted proteins need to be delivered directly to the cell surface. Sorting of secreted proteins from the Golgi apparatus has been a topic of interest for over thirty years, yet there is still no clear understanding of the machinery that forms the post-Golgi carriers. Most evidence points to these post-Golgi carriers being tubular pleomorphic structures that bud from the trans-face of the Golgi. In this review, we present the background studies and highlight the key components of this pathway, we then discuss the machinery implicated in the formation of these carriers, their translocation across the cytosol, and their fusion at the plasma membrane
Recommended from our members
A Short Sequence Targets Transmembrane Proteins to Primary Cilia
Primary cilia are finger-like sensory organelles that extend from the bodies of most cell
types and have a distinct lipid and protein composition from the plasma membrane. This
partitioning is maintained by a diffusion barrier that restricts the entry of non-ciliary proteins, and
allows the selective entry of proteins harboring a ciliary targeting sequence (CTS). However, CTSs
are not stereotyped, and previously-reported sequences are insufficient to drive efficient ciliary
localization across diverse cell types. Here, we describe a short peptide sequence that efficiently
targets transmembrane proteins to primary cilia in all tested cell types, including human neurons.
We generate human induced pluripotent stem cell (hiPSC) lines stably expressing a
transmembrane construct bearing an extracellular HaloTag and intracellular fluorescent protein,
that enables bright, specific labeling of primary cilia in neurons and other cell types to facilitate
studies of cilia in health and disease. We demonstrate the utility of this resource by developing an
image analysis pipeline for the automated measurement of primary cilia to detect changes in their
length associated with altered signaling or disease state.New York Stem Cell Foundation [NYSCF-R-156];
Chan Zuckerberg Initiative [CZI NDCN 191942,
10.37921/429861umrcjh]; Wellcome Trust [211221/Z/18/Z, Grant 210481]; BBSRC [BB/W005905/1]; Medical Research Council
Doctoral Training Programme and the School of Clinical Medicine Cambridge Trust Scholarshi
Routes to and from the plasma membrane: bulk flow versus signal mediated endocytosis
Transport of proteins via the secretory pathway is controlled by a combination of signal dependent cargo selection as well as unspecific bulk flow of membranes and aqueous lumen. Using the plant vacuolar sorting receptor as model for membrane spanning proteins, we have distinguished bulk flow from signal mediated protein targeting in biosynthetic and endocytic transport routes and investigated the influence of transmembrane domain length. More specifically, long transmembrane domains seem to prevent ER retention, either by stimulating export or preventing recycling from post ER compartments. Long transmembrane domains also seem to prevent endocytic bulk flow from the plasma membrane, but the presence of specific endocytosis signals overrules this in a dominant manner